GlassScriptPhysician profile
Stuart D Katchis
NPI 1366638439
$636,508.17
in general payments reported to CMS, 2019-2025
22 companies · $3,178 in 2025
The $3,178 reported for 2025 was more than what 77% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145K · 2020: $78K · 2021: $79K · 2022: $269K · 2023: $52K · 2024: $9,544 · 2025: $3,178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $61K · Consulting Fee: $3,270 · Food and Beverage: $786.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $61,052.24 |
| Consulting Fee | $3,270.00 |
| Food and Beverage | $785.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medartis INC. | $331,143.97 | 2022-2025 | Aptus |
| Nextremity Solutions INC. | $268,444.63 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $35,199.02 | 2019-2024 | Compr Aug Mini Cptrd Pn Plcmnt Gd Lg (Sup), Tapestry, Gps III Platelet Concentration System |
| Stryker Corporation | $296.61 | 2021-2025 | Inbone, Prostep Mica, Ortholoc 2 Lapifuse |
| Treace Medical Concepts, INC. | $136.00 | 2022-2025 | |
| Depuy Synthes Sales INC. | $134.44 | 2022 | |
| Terumo Bct, INC. | $134.05 | 2020 | |
| Sanara Medtech INC. | $121.61 | 2022-2024 | Celleraterx |
| Wright Medical Technology, INC. | $120.20 | 2019 | |
| Baxter Healthcare | $117.58 | 2019-2025 | Actifuse |
| Abbott Laboratories | $113.28 | 2024-2025 | Swift-Lock, Proclaim |
| Arteriocyte Medical Systems, INC. | $86.57 | 2019-2021 | |
| Suvon Surgical LLC | $82.19 | 2023-2025 | |
| Trilliant Surgical LLC. | $72.86 | 2025 | Minimally Invasive Bunion Plate, Left |
| Paragon 28, INC. | $64.41 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $56.03 | 2021-2022 | |
| Bioventus LLC | $53.67 | 2019-2022 | |
| Djo, LLC | $44.70 | 2021 | |
| Kci USA, INC. | $28.33 | 2023 | Prevena, V.A.C. Dermatac, V.A.C. Veraflo |
| Acell, INC. | $23.50 | 2019 | |
| Ferring Pharmaceuticals INC. | $17.87 | 2019 | |
| Smith+Nephew, INC. | $16.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,314,868.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Katchis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.